Zions Bancorporation N.A. Increases Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Zions Bancorporation N.A. grew its stake in HealthEquity, Inc. (NASDAQ:HQY) by 17.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 24,244 shares of the company’s stock after acquiring an additional 3,636 shares during the quarter. Zions Bancorporation N.A.’s holdings in HealthEquity were worth $2,326,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the stock. EFG Asset Management North America Corp. grew its position in HealthEquity by 103.8% during the 4th quarter. EFG Asset Management North America Corp. now owns 45,647 shares of the company’s stock valued at $4,382,000 after purchasing an additional 23,247 shares during the last quarter. EntryPoint Capital LLC purchased a new stake in shares of HealthEquity during the fourth quarter valued at approximately $591,000. Summit Creek Advisors LLC raised its holdings in HealthEquity by 11.0% in the 4th quarter. Summit Creek Advisors LLC now owns 285,913 shares of the company’s stock worth $27,433,000 after acquiring an additional 28,424 shares during the last quarter. Vanguard Group Inc. lifted its position in HealthEquity by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company’s stock valued at $861,256,000 after acquiring an additional 99,624 shares in the last quarter. Finally, LPL Financial LLC boosted its stake in HealthEquity by 11.8% during the 4th quarter. LPL Financial LLC now owns 42,256 shares of the company’s stock valued at $4,211,000 after purchasing an additional 4,451 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on HQY. Wells Fargo & Company upped their price target on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a report on Wednesday, February 26th. Mizuho started coverage on shares of HealthEquity in a report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target on the stock. KeyCorp decreased their price objective on shares of HealthEquity from $120.00 to $110.00 and set an “overweight” rating for the company in a report on Monday. Raymond James upgraded shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and dropped their target price for the stock from $120.00 to $115.00 in a report on Tuesday. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $112.00 target price on shares of HealthEquity in a research report on Friday, March 14th. One investment analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $113.31.

HealthEquity Stock Performance

NASDAQ:HQY opened at $90.19 on Wednesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock has a 50-day simple moving average of $104.40 and a two-hundred day simple moving average of $95.94. The firm has a market capitalization of $7.80 billion, a PE ratio of 82.74, a P/E/G ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59.

Insider Activity

In other news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 2.20% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.